Catalyst Wire Dossier Catalyst Wire Dossier

JUXTAPID

lomitapide · Amryt Pharmaceuticals DAC
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for JUXTAPID, covering 2012-12-21 to 2026-02-25. Get the full timeline:

Most recent: FDA Approved: JUXTAPID — Supplemental Application (Amryt Pharmaceuticals DAC)

See pricing